Nicklas Claudia, Rubio Rocío, Cárdenas Consuelo, Hasson Ariel
Dermatology Department, Universidad de La Frontera, Temuco, Chile.
Dermatology Department, Pontificia Universidad Católica de Chile, Santiago de Chile, Chile.
Photodermatol Photoimmunol Photomed. 2019 Jan;35(1):3-10. doi: 10.1111/phpp.12413. Epub 2018 Jul 26.
Although progress has been made in the study of photodynamic therapy for acne, studies using current recommended therapies as active comparators are lacking.
Randomized, controlled trial involving 46 patients with moderate inflammatory facial acne, 23 patients received two sessions of PDT separated by 2 weeks (ALA 20% incubated 1.5 hours before red light irradiation with 37 J/cm fluence) and 23 patients received doxycycline 100 mg/d plus adapalene gel 0.1%. In both groups, from the sixth week, we started adapalene gel 0.1% as maintenance therapy until 12 weeks of follow-up. Primary end point was the reduction of acne lesions at the 6-week follow-up, which was evaluated by 2 investigators blinded to the intervention.
The median percent reductions in noninflammatory lesion count (P = 0.013) and total lesions (P = 0.038) at 6 weeks was found to be significantly higher in the group receiving PDT. At 12 weeks there was a greater reduction of inflammatory lesions in PDT group with 84% vs. 74% for group who received doxycycline plus adapalene (P = 0.020) as well as in reducing total lesions with 79% vs. 67% respectively (P = 0.026). No severe side-effects were observed for either therapy.
ALA-PDT offers promise as an alternative treatment for moderately severe inflammatory acne that has a higher effectiveness than the combination of doxycycline and adapalene gel in reducing noninflammatory and total lesions at 6 weeks. There were significantly superior reductions at 12 weeks in the combination of PDT group followed by adapalene gel in total, inflammatory, and noninflammatory lesions.
尽管光动力疗法治疗痤疮的研究已取得进展,但缺乏以当前推荐疗法作为活性对照的研究。
一项随机对照试验,纳入46例中度炎性面部痤疮患者,23例患者接受间隔2周的两次光动力治疗(20%氨基乙酰丙酸孵育1.5小时后用37 J/cm的能量密度进行红光照射),23例患者接受每日100 mg强力霉素加0.1%阿达帕林凝胶治疗。两组均从第6周开始使用0.1%阿达帕林凝胶作为维持治疗,直至随访12周。主要终点是6周随访时痤疮皮损的减少情况,由两名对干预不知情的研究者进行评估。
发现接受光动力治疗的组在6周时非炎性皮损计数(P = 0.013)和总皮损数(P = 0.038)的中位数减少百分比显著更高。在12周时,光动力治疗组的炎性皮损减少幅度更大,分别为84%,而接受强力霉素加阿达帕林凝胶治疗的组为74%(P = 0.020),总皮损减少率分别为79%和67%(P = 0.026)。两种治疗均未观察到严重副作用。
氨基乙酰丙酸光动力疗法有望成为中度重度炎性痤疮的替代治疗方法,在减少6周时的非炎性和总皮损方面比强力霉素和阿达帕林凝胶联合治疗更有效。在12周时,光动力治疗组联合阿达帕林凝胶后,在总皮损、炎性皮损和非炎性皮损方面的减少幅度显著更大。